Skip to main content

Bio-Rad, Institut Pasteur Extend Alliance Through End of Decade

NEW YORK, Jan. 4 (GenomeWeb News) - Bio-Rad Laboratories and the Institut Pasteur have extended their cooperation an additional four years, Bio-Rad said today.


The agreement, signed in Paris last month, gives Bio-Rad exclusive commercialization rights to Pasteur's research developments in the areas of virology, microbiology, physiology, biochemistry, parasitology and mycology, Bio-Rad said.


Norman Schwartz, president of the Hercules, Calif.-based company, said that Institut Pasteur "provides important innovations affecting blood virus testing," and that the institute's research is "closely aligned" with Bio-Rad's goal to supply the healthcare community with diagnostic tools.  


Bio-Rad and Pasteur have been collaborating since 1990, the company said.


Financial details of the agreement were not dislosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.